MAPK3 and melanoma: The CSPG4-specific scFv-Fc antibody reduced phosphorylation of both ERK1/2 and FAK by over 60% in CSPG4-positive cell lines, including melanoma, in the absence of immune effector cells, suggesting the suppression of melanoma growth through direct, Fab-mediated effects.